Thelium Therapeutics

San Carlos, United States

Thelium Therapeutics is an early-stage preclinical company that develops agents to restore the intestinal barriers in inflammatory diseases.

$18.0M raised

May 2022

Venture - Series Unknown

Biotechnology Health Care Therapeutics

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Thelium Therapeutics

How much funding has Thelium Therapeutics raised?

Thelium Therapeutics has raised $18.0M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in May 2022.

Where is Thelium Therapeutics headquartered?

Thelium Therapeutics is headquartered in San Carlos, United States.

What does Thelium Therapeutics do?

Thelium Therapeutics is an early-stage preclinical company that develops agents to restore the intestinal barriers in inflammatory diseases.

What stage is Thelium Therapeutics at?

Thelium Therapeutics is at the Venture - Series Unknown stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated May 5, 2022.

MLA

"Thelium Therapeutics — Funding & Investors." VCBacked, May 5, 2022, https://www.vcbacked.co/company/thelium-therapeutics. Accessed July 2, 2026.

APA

VCBacked. (2022). Thelium Therapeutics — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/thelium-therapeutics

Wikipedia (cite web)

{{cite web |title=Thelium Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/thelium-therapeutics |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated May 5, 2022.